These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29897440)

  • 41. Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
    Porco TC; Hart J; Arzika AM; Weaver J; Kalua K; Mrango Z; Cotter SY; Stoller NE; O'Brien KS; Fry DM; Vanderschelden B; Oldenburg CE; West SK; Bailey RL; Keenan JD; Lietman TM;
    Clin Infect Dis; 2019 May; 68(12):2114-2116. PubMed ID: 30561577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the field.
    Maher MC; Alemayehu W; Lakew T; Gaynor BD; Haug S; Cevallos V; Keenan JD; Lietman TM; Porco TC
    PLoS One; 2012; 7(1):e29407. PubMed ID: 22272234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Cross-Sectional Study of the Availability of Azithromycin in Local Pharmacies and Associated Antibiotic Resistance in Communities in Kilosa District, Tanzania.
    Ansah D; Weaver J; Munoz B; Bloch EM; Coles CL; Lietman T; West SK
    Am J Trop Med Hyg; 2019 May; 100(5):1105-1109. PubMed ID: 30915951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
    Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of erythromycin resistance and macrolide-resistance genes, mefA and ermB, in Streptococcus pneumoniae isolates from the upper respiratory tracts of children in the Sapporo district, Japan.
    Harimaya A; Yokota S; Sato K; Yamazaki N; Himi T; Fujii N
    J Infect Chemother; 2007 Aug; 13(4):219-23. PubMed ID: 17721684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
    Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
    Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
    Arzika AM; Maliki R; Abdou A; Mankara AK; Harouna AN; Cook C; Hinterwirth A; Worden L; Zhong L; Chen C; Ruder K; Zhou Z; Lebas E; O'Brien KS; Oldenburg CE; Le V; Arnold BF; Porco TC; Keenan JD; Lietman TM; Doan T
    Clin Infect Dis; 2021 Oct; 73(7):1292-1295. PubMed ID: 34037753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013.
    Liu B; Cowling C; Hayen A; Watt G; Mak DB; Lambert S; Taylor H; Kaldor JM
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004810. PubMed ID: 27385309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma.
    Keenan JD; Sahlu I; McGee L; Cevallos V; Vidal JE; Chochua S; Hawkins P; Gebre T; Tadesse Z; Emerson PM; Gaynor BD; Lietman TM; Klugman KP
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):222-6. PubMed ID: 27199475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
    House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
    Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.
    Oldenburg CE; Amza A; Cooley G; Kadri B; Nassirou B; Arnold BF; Rosenthal PJ; O'Brien KS; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Martin DL
    Malar J; 2019 Dec; 18(1):389. PubMed ID: 31796025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
    West SK; Bailey R; Munoz B; Edwards T; Mkocha H; Gaydos C; Lietman T; Porco T; Mabey D; Quinn TC
    PLoS Negl Trop Dis; 2013; 7(8):e2415. PubMed ID: 24009792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.
    Doan T; Arzika AM; Hinterwirth A; Maliki R; Zhong L; Cummings S; Sarkar S; Chen C; Porco TC; Keenan JD; Lietman TM;
    N Engl J Med; 2019 Jun; 380(23):2271-2273. PubMed ID: 31167060
    [No Abstract]   [Full Text] [Related]  

  • 55. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients.
    Dagan R; Leibovitz E; Greenberg D; Yagupsky P; Fliss DM; Leiberman A
    Pediatr Infect Dis J; 1998 Oct; 17(10):880-5. PubMed ID: 9802628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier children.
    Swedan SF; Hayajneh WA; Bshara GN
    Indian J Med Microbiol; 2016; 34(2):159-65. PubMed ID: 27080766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
    Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
    Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial.
    O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; Cotter C; West SK; Bailey RL; Rosenthal PJ; Gaynor BD; Porco TC; Lietman TM
    Am J Trop Med Hyg; 2017 Sep; 97(3):696-701. PubMed ID: 28722569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.
    Leach AJ; Shelby-James TM; Mayo M; Gratten M; Laming AC; Currie BJ; Mathews JD
    Clin Infect Dis; 1997 Mar; 24(3):356-62. PubMed ID: 9114185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.